Off-label use of recombinant human factor VIIa

Ann Thorac Surg. 2014 Aug;98(2):393-5. doi: 10.1016/j.athoracsur.2014.06.007.

Authors

Lawrence Tim Goodnough¹, Jerrold H Levy²

Affiliations

¹ Stanford University Medical Center, Stanford University, Stanford, California. Electronic address: ltgoodno@stanford.edu.
² Department of Anesthesiology, Duke University School of Medicine, Durham, North Carolina.

PMID: 25087781
DOI: 10.1016/j.athoracsur.2014.06.007

No abstract available

Publication types

Editorial
Comment

MeSH terms

Cardiac Surgical Procedures / mortality*
Factor VIIa / adverse effects*
Female
Humans
Male
Recombinant Proteins / adverse effects

Substances

Recombinant Proteins
recombinant FVIIa
Factor VIIa